LifeVantage (NASDAQ:LFVN) Posts Quarterly Earnings Results

Share on StockTwits

LifeVantage (NASDAQ:LFVN) issued its quarterly earnings data on Monday, February 4th. The company reported $0.13 earnings per share (EPS) for the quarter, reports. The business had revenue of $58.17 million during the quarter. LifeVantage had a return on equity of 35.08% and a net margin of 2.92%. LifeVantage updated its FY 2019 guidance to $0.46-0.52 EPS.

Shares of NASDAQ LFVN opened at $14.73 on Tuesday. LifeVantage has a 12-month low of $3.20 and a 12-month high of $17.08. The company has a market cap of $210.40 million, a PE ratio of 28.88 and a beta of 0.80. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.52 and a quick ratio of 1.06.

Several large investors have recently made changes to their positions in the company. Creative Planning acquired a new stake in LifeVantage during the 3rd quarter valued at $122,000. Raymond James & Associates acquired a new stake in LifeVantage during the 4th quarter valued at $174,000. Man Group plc acquired a new stake in LifeVantage during the 3rd quarter valued at $147,000. Marshall Wace LLP acquired a new position in shares of LifeVantage in the third quarter worth $167,000. Finally, Tower Research Capital LLC TRC increased its stake in shares of LifeVantage by 44.7% in the second quarter. Tower Research Capital LLC TRC now owns 16,467 shares of the company’s stock worth $105,000 after acquiring an additional 5,085 shares during the last quarter. Institutional investors own 28.29% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by Fairfield Current and is owned by of Fairfield Current. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Featured Story: Cost of Capital

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with's FREE daily email newsletter.

Leave a Reply